News
-
AstraZeneca and NVIDIA spur healthech revolution via Cambridge-1 supercomputer
NVIDIA is collaborating with Cambridge UK headquartered Big Biotech business AstraZeneca and the University of Florida’s academic health centre UF... Read More
-
Amazing ‘Grace’ as NVIDIA ramps Arm technology propositions
The Arm ecosystem, rooted in Cambridge but globally prolific, received a booster shot of advances from NVIDIA at its technology showcase, GTC... Read More
-
High profile new chair to spur fresh growth for Nu Quantum
Nu Quantum, the Cambridge quantum photonics company, is pushing its technology harder and faster globally following the appointment of a high profile... Read More
-
Domino rolls out gamechanging visual technology
Cambridge coding and marking technology world-leader Domino Printing has strengthened its capability to deliver fast and efficient support to global... Read More
-
Healx approaches seminal US clinical trial milestone
Cambridge rare disease specialist Healx has struck its latest patient group partnership – with Ataxia UK and FARA, The Friedreich’s Ataxia Research... Read More
-
Boyds launches recruitment drive after surge in growth
Turnover at Cambridge pharmaceutical and biotech product development consultancy Boyds has surged by a record-breaking 25 per cent as demand for its... Read More
-
Evonetix attracts top product chief to accelerate scale-up
Evonetix has appointed Dr Michael Daniels as head of product management. Dr Daniels will be responsible for defining the roadmap for Evonetix’ DNA... Read More
-
Rosetta Capital buys into Cambridge drug discovery firm’s ‘Mission’
Mission Therapeutics, the Cambridge-based drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs),... Read More
-
‘Can’ do philosophy pays off for Tonejet
Cambridge printing technology pioneer Tonejet has made a giant stride into the craft beverage industry with an order from Bevcraft for its Cyclone... Read More
-
Illumina hits record Q1 revenue and fights US trade chiefs over GRAIL
Illumina, whose European research HQ is in Cambridge, has posted record Q1 revenues for 2021 in its preliminary results and forecasts a major... Read More
-
Cambridge A-listers combine in SARS-CoV-2 move
Avacta Group plc, a developer of innovative cancer therapies and diagnostics, has agreed a global distribution deal with Cambridge neighbour Abcam to... Read More
-
Artios clinches minimum $1.5bn from Novartis for cancer assault
Artios Pharma, based on the Babraham Research Campus in Cambridge, has clinched a megabucks deal with Novartis that is worth at least $1.5 billion... Read More
-
Start Codon and Cancer Research UK stage startups seminar
One year ago Start Codon announced a partnership with Cancer Research UK and their intent to work together to focus on the Cambridge UK cluster by... Read More
-
Full steam ahead for Darktrace IPO as top team blossoms
Cambridge-based cyber security world leader Darktrace has further strengthened its top team in preparation for its upcoming multi-billion dollar IPO... Read More
-
Clear Covid mask set for panoramic success
The development of a unique clear facemask designed by the Clinical Engineering Innovation team at Addenbrooke’s Hospital in Cambridge has passed... Read More
-
1Spatial clinches £0.9m Defra deal
Cambridge locational software company 1Spatial has secured a multi-year contract worth £0.9 million with Defra – the Department for Environment, Food... Read More
-
Arm sets new compute agenda with revolutionary v9 technology
Cambridge superchip architect Arm has unleashed its most powerful ever technology suite to define the future of cross-the-board compute. In a move... Read More
-
Arecor wins £2.8m from Innovate UK to boost fight against diabetes
Cambridge biopharma business Arecor has been awarded a £2.8 million grant from Innovate UK to support the Phase II development of AT247, an ultra-... Read More
-
Eckoh wins $11.6m of new US contracts
Payment products pioneer Eckoh plc is on a hot streak of contract wins through its novel US Secure Payments operation. Since the start of... Read More
-
Horizon shows teeth as wolf of Wall Street with tech advance
Cambridge gene editing world leader Horizon Discovery has strengthened its technology hand with a shrewd advance. Now under the ownership of Wall... Read More